199 related articles for article (PubMed ID: 1788163)
21. In-situ ocular absorption of ophthalmic beta-blockers through ocular membranes in albino rabbits.
Sasaki H; Ichikawa M; Kawakami S; Yamamura K; Mukai T; Nishida K; Nakamura J
J Pharm Pharmacol; 1997 Feb; 49(2):140-4. PubMed ID: 9055184
[TBL] [Abstract][Full Text] [Related]
22. Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera.
Hämäläinen KM; Kananen K; Auriola S; Kontturi K; Urtti A
Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):627-34. PubMed ID: 9071216
[TBL] [Abstract][Full Text] [Related]
23. Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea.
Ahmed I; Gokhale RD; Shah MV; Patton TF
J Pharm Sci; 1987 Aug; 76(8):583-6. PubMed ID: 11002815
[TBL] [Abstract][Full Text] [Related]
24. Ophthalmic preservatives as absorption promoters for ocular drug delivery.
Sasaki H; Nagano T; Yamamura K; Nishida K; Nakamura J
J Pharm Pharmacol; 1995 Sep; 47(9):703-7. PubMed ID: 8583378
[TBL] [Abstract][Full Text] [Related]
25. Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine.
Kyyrönen K; Urtti A
Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1827-33. PubMed ID: 2211028
[TBL] [Abstract][Full Text] [Related]
26. The transcorneal penetration of commercial ophthalmic formulations containing timolol maleate in rabbit eyes.
Fukuda M; Sasaki H
J Ocul Pharmacol Ther; 2015 Feb; 31(1):57-60. PubMed ID: 25303115
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits.
Pisella PJ; Fillacier K; Elena PP; Debbasch C; Baudouin C
Ophthalmic Res; 2000; 32(1):3-8. PubMed ID: 10657748
[TBL] [Abstract][Full Text] [Related]
28. Ultrastructural effects of topical beta-adrenergic antagonists and an alpha-adrenergic agonist on the rabbit cornea.
Polat S; Ozdemir N; Soylu M; Mete U; Unlügenç Z; Kaya M
Ophthalmologica; 1999; 213(3):183-8. PubMed ID: 10202292
[TBL] [Abstract][Full Text] [Related]
29. Nasal and conjunctival contributions to the systemic absorption of topical timolol in the pigmented rabbit: implications in the design of strategies to maximize the ratio of ocular to systemic absorption.
Chang SC; Lee VH
J Ocul Pharmacol; 1987; 3(2):159-69. PubMed ID: 3503911
[TBL] [Abstract][Full Text] [Related]
30. Application site dependent ocular absorption of timolol.
Urtti A; Sendo T; Pipkin JD; Rork G; Repta AJ
J Ocul Pharmacol; 1988; 4(4):335-43. PubMed ID: 3246568
[TBL] [Abstract][Full Text] [Related]
31. Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions.
Liang H; Brignole-Baudouin F; Riancho L; Baudouin C
Ophthalmic Res; 2012; 48(2):89-101. PubMed ID: 22473057
[TBL] [Abstract][Full Text] [Related]
32. Topical ocular pharmacokinetics and bioavailability for a cocktail of atenolol, timolol and betaxolol in rabbits.
Fayyaz A; Ranta VP; Toropainen E; Vellonen KS; Valtari A; Puranen J; Ruponen M; Gardner I; Urtti A; Jamei M; Del Amo EM
Eur J Pharm Sci; 2020 Dec; 155():105553. PubMed ID: 32946960
[TBL] [Abstract][Full Text] [Related]
33. Effect of benzalkonium chloride/EDTA on the ocular bioavailability of ketorolac tromethamine following ocular instillation to normal and de-epithelialized corneas of rabbits.
Madhu C; Rix PJ; Shackleton MJ; Nguyen TG; Tang-Liu DD
J Pharm Sci; 1996 Apr; 85(4):415-8. PubMed ID: 8901080
[TBL] [Abstract][Full Text] [Related]
34. Preparation and evaluation of a timolol maleate drug-resin ophthalmic suspension as a sustained-release formulation in vitro and in vivo.
Qin F; Zeng L; Zhu Y; Cao J; Wang X; Liu W
Drug Dev Ind Pharm; 2016; 42(4):535-45. PubMed ID: 26368660
[TBL] [Abstract][Full Text] [Related]
35. The effect of chlorhexidine acetate on the corneal penetration of sorbitol from an arnolol formulation in the albino rabbit.
Ashton P; Diepold R; Platzer A; Lee VH
J Ocul Pharmacol; 1990; 6(1):37-42. PubMed ID: 2362159
[TBL] [Abstract][Full Text] [Related]
36. Corneal and conjunctival/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes.
Chien DS; Homsy JJ; Gluchowski C; Tang-Liu DD
Curr Eye Res; 1990 Nov; 9(11):1051-9. PubMed ID: 1982760
[TBL] [Abstract][Full Text] [Related]
37. Ocular membrane permeability of hydrophilic drugs for ocular peptide delivery.
Sasaki H; Ichikawa M; Yamamura K; Nishida K; Nakamura J
J Pharm Pharmacol; 1997 Feb; 49(2):135-9. PubMed ID: 9055183
[TBL] [Abstract][Full Text] [Related]
38. Effects of topical timolol (0.5%) and betaxolol (0.5%) on corneal sensitivity.
Weissman SS; Asbell PA
Br J Ophthalmol; 1990 Jul; 74(7):409-12. PubMed ID: 2378856
[TBL] [Abstract][Full Text] [Related]
39. Cidofovir transport in the pigmented rabbit conjunctiva.
Hosoya K; Lee VH
Curr Eye Res; 1997 Jul; 16(7):693-7. PubMed ID: 9222087
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the effects of topical levobunolol and timolol solution on the human ocular surface.
Ishibashi T; Yokoi N; Kinoshita S
Cornea; 2003 Nov; 22(8):709-15. PubMed ID: 14576520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
